Volume 10, Number 5—May 2004
Research
Clinical Manifestations, Laboratory Findings, and Treatment Outcomes of SARS Patients
Jann-Tay Wang*, Wang-Huei Sheng*, Chi-Tai Fang*, Yee-Chun Chen*, Jiun-Ling Wang*, Chong-Jen Yu*, Shan-Chwen Chang*
, and Pan-Chyr Yang*
, and Pan-Chyr Yang*
Table 5
Univariate analysis of factors predictive for death and respiratory failure (logistic regression)a
| Factors | Odds ratio |
p value |
|||
|---|---|---|---|---|---|
| Mortality | ResF | Mortality | ResF | ||
| Age (every 1 y)b |
1.093 |
1.082 |
<0.001 |
<0.001 |
|
| Sex (male to female) |
3.086 |
2.841 |
0.064 |
0.036 |
|
| Severe underlying diseasec |
3.973 |
3.023 |
<0.001 |
<0.001 |
|
| Initial CRP levelb,c (every 1 mg/dL) |
1.300 |
1.391 |
0.004 |
<0.001 |
|
| Initial ANC count (every 0.1x109/L) |
1.022 |
1.031 |
0.020 |
0.006 |
|
| Initial lymphocyte count (every 0.1x109/L) |
0.091 |
0.916 |
0.188 |
0.162 |
|
| Initial platelet count (every 100x109/L) |
0.668 |
0.565 |
0.485 |
0.248 |
|
| Initial CXR findings (every one-lobe involvement) |
1.482 |
1.941 |
0.154 |
0.025 |
|
| Peak CRP level (every 1 mg/dL) |
1.193 |
1.385 |
0.033 |
<0.001 |
|
| Lowest lymphocyte count (every 0.1x109/L) |
0.801 |
0.804 |
0.079 |
0.032 |
|
| Peak LDH level (every 100 U/L) |
1.132 |
1.160 |
0.124 |
0.008 |
|
| Peak CK level (every 1 U/L) |
1.093 |
1.082 |
<0.001 |
<0.001 |
|
| Lowest platelet count (every 100x109/L) |
0.724 |
0.541 |
0.608 |
0.261 |
|
| Worst CXR findings (every one-lobe involvement) a | 1.505 | 2.147 | 0.064 | <0.001 | |
aResF, respiratory failure; CRP, C-reactive protein; ANC, absolute neutrophil count; CXR, chest radiography; LDH, lactate dehydrogenase; CK, creatine kinase.
bFactors that remained statistically significant after multivariate analysis for respiratory failure.
cFactors that remained statistically significant after multivariate analysis for death.
Page created: February 22, 2011
Page updated: February 22, 2011
Page reviewed: February 22, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.